Recent Market Performance and Price Movements
On 4 Feb 2026, GPT Healthcare Ltd opened sharply lower with a gap down of -4.42%, touching an intraday low of Rs.123.15, which represents its lowest price ever recorded. The stock underperformed its sector by -1.04% on the day and closed with a decline of -1.24%, contrasting with the Sensex’s modest gain of 0.11%. The downward momentum is further underscored by the stock trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish sentiment.
Over the short and medium term, GPT Healthcare’s returns have been notably weak. The stock has declined by -0.55% over the past week and -10.39% over the last month, while the Sensex gained 1.80% and lost only -2.25% respectively during these periods. The three-month performance shows a -14.37% drop for GPT Healthcare compared to a 0.44% rise in the Sensex. Year-to-date, the stock is down -9.27%, underperforming the Sensex’s -1.63% loss.
Long-Term Underperformance
GPT Healthcare’s challenges extend over a longer horizon. The stock has delivered a negative return of -24.35% in the last year, while the Sensex rose by 6.68%. Over three and five years, the stock has effectively stagnated with 0.00% returns, whereas the Sensex has surged by 37.78% and 65.62% respectively. Over a decade, the contrast is even starker, with the Sensex appreciating by 244.43% while GPT Healthcare has not recorded any growth in share price.
Financial Metrics and Profitability Trends
The company’s operating profit has contracted at an annualised rate of -10.80% over the past five years, reflecting subdued growth in core earnings. GPT Healthcare has reported negative results for three consecutive quarters, indicating ongoing pressures on profitability. Interest expenses have risen sharply, growing by 66.79% to Rs.4.42 crores over the latest six-month period, which has impacted the company’s ability to generate operating profit relative to interest costs. The operating profit to interest ratio has fallen to a low of 9.16 times, signalling tighter coverage.
Return on Capital Employed (ROCE) for the half-year period stands at 18.76%, which is the lowest recorded level for the company. Despite this, management efficiency remains relatively strong with a higher ROCE figure of 25.62% noted in other assessments, suggesting some operational strengths amid the broader challenges.
Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!
- - Recently turned profitable
- - Strong business fundamentals
- - Pre-breakout opportunity
Debt and Valuation Considerations
GPT Healthcare maintains a relatively low Debt to EBITDA ratio of 0.53 times, indicating a manageable debt burden and a strong ability to service its obligations. The company’s enterprise value to capital employed ratio stands at 3.5, which is considered very attractive in valuation terms. This suggests that the stock is trading at a discount relative to its peers’ historical valuations.
However, despite these valuation metrics, the company’s profits have declined by -18.7% over the past year, which aligns with the negative share price performance. The combination of falling profits and subdued returns has contributed to the stock’s current status at an all-time low.
Institutional Investor Activity
Institutional investors have reduced their holdings by -0.72% over the previous quarter, now collectively holding 8.94% of the company’s shares. This decline in institutional participation may reflect a reassessment of the company’s fundamentals by investors with greater analytical resources, adding to the downward pressure on the stock price.
Comparative Performance Within the Sector
GPT Healthcare’s underperformance is evident not only against the Sensex but also relative to the BSE500 index and its hospital sector peers. The stock has lagged behind the BSE500 over the last three years, one year, and three months, highlighting persistent challenges in generating competitive returns within its industry segment.
Holding GPT Healthcare Ltd from Hospital? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Mojo Score and Rating Update
GPT Healthcare currently holds a Mojo Score of 36.0, reflecting a cautious outlook on the stock’s prospects. The Mojo Grade was downgraded from Hold to Sell on 30 Sep 2025, signalling a reassessment of the company’s risk and return profile. The Market Cap Grade stands at 3, indicating a moderate market capitalisation relative to other listed entities.
Summary of Key Financial and Market Indicators
To summarise, GPT Healthcare Ltd’s stock has reached an unprecedented low of Rs.123.15, driven by a combination of declining profitability, increased interest expenses, reduced institutional participation, and sustained underperformance against market benchmarks. While certain financial metrics such as debt servicing capacity and valuation ratios remain favourable, the overall trend remains subdued with negative returns across multiple timeframes.
The stock’s recent trading patterns, including its position below all major moving averages and its gap down opening, underscore the prevailing market sentiment. The downgrade in Mojo Grade to Sell further reflects the challenges faced by the company in reversing its downtrend.
Investors and market participants continue to monitor GPT Healthcare’s financial disclosures and market movements closely as the stock navigates this extended period of weakness.
Unlock special upgrade rates for a limited period. Start Saving Now →
